v2.4.0.6
Acquisitions (Schedule Of Assets Acquired And Liabilities Assumed) (Details) (CV Therapeutics, Inc. [Member], USD $)
Apr. 15, 2009
Business Acquisition, Contingent Consideration [Line Items]  
Goodwill $ 341,910,000
Deferred tax assets 413,816,000
Deferred tax liabilities (426,861,000)
Cash and cash equivalents 129,087,000
Marketable securities 116,363,000
Accounts receivable 9,136,000
Inventories 50,455,000
Prepaids and other current assets 60,671,000
Property, plant and equipment 11,672,000
Other assets 20,162,000
Accounts payable (5,089,000)
Accrued and other current liabilities (87,898,000)
Convertible senior notes (303,060,000)
Other liabilities (27,906,000)
Total other net liabilities (26,407,000)
Total consideration transferred 1,392,558,000
Marketed Products [Member]
  
Business Acquisition, Contingent Consideration [Line Items]  
Intangible assets - marketable products 951,200,000
Intangible Assets - IPR&D [Member]
  
Business Acquisition, Contingent Consideration [Line Items]  
Intangible assets - IPR&D $ 138,900,000